-
MLV & Co Reiterates Buy, $4.50 PT on ImmunoCellular Therapeutics on Move to NYSE
Friday, May 25, 2012 - 12:20pmMLV & Co reiterates its Buy rating with a $4.50 price target on ImmunoCellular Therapeutics (NYSE: IMUC) as the company gets its listing on the NYSE starting next week. MLV & Co comments, "We view this move as an affirmation of the company's commitment to growing their pipeline, and...
Read More >> -
UPDATE: National Alliance Raises PT to $20.27 on Take Two Interactive on Product Catalyst within Fiscal Year.
Friday, May 25, 2012 - 12:19pmNational Alliance reiterates its Buy rating on Take Two Interactive (NASDAQ: TTWO) and raises its price target from $19.85 to $20.27. National Alliance notes, "We believe the Company's negative price action into fiscal Q4'12 earnings came from increased speculation that GTA V would be released...
Read More >> -
Maxim Group Maintains Buy, $38 PT on Cree Post CFO Departure
Friday, May 25, 2012 - 10:51amMaxim Group remains rated Buy with a $38 price target on Cree (NASDAQ: CREE) following the company's CFO departure. Maxim Group comments, "In the Face of Fanning Fears, CFO Departure Is a Logical Step at this Stage of Growth and Presages Further Transition from a Tech to a Lighting Company. …On...
Read More >> -
UPDATE: Credit Suisse Cuts PT to C$56 on Royal Bank of Canada on Slight Quarterly Miss
Friday, May 25, 2012 - 10:00amCredit Suisse reiterates its Neutral rating on Royal Bank of Canada (NYSE: RY) and reduces its price target from C$57 to C$56. Credit Suisse comments, "One of the negative surprises in the quarter was an uptick in commercial credit losses that RY attributed to two specific loans. These can be...
Read More >> -
UPDATE: Credit Suisse Reinstates Carrizo Oil & Gas to Neutral with PT of $30 on Continuing Liquids Transition
Friday, May 25, 2012 - 10:00amCredit Suisse resumes coverage on Carrizo Oil & Gas (NASDAQ: CRZO) with a Neutral rating and a price target of $30. Credit Suisse notes, "Reinstating Coverage, Transition to Liquids Continues. With the recent closing of its non-operated Barnett divestiture (closed on 5/1/12), CRZO is now...
Read More >> -
Piper Jaffray Comments on April Sales Data for Mattress Industry
Friday, May 25, 2012 - 9:44amPiper Jaffray has published a research report commenting on April sales data for the mattress industry, including Select Comfort (NASDAQ: SCSS), Tempur-Pedic International (NYSE: TPX) and Sealy (NYSE: ZZ). In the report, Piper Jaffray writes, "April sales data for the mattress industry (...
Read More >> -
Bank of America: PayPal's Offline Merchants
Friday, May 25, 2012 - 9:21amIn a research report published this morning by Bank of America, eBay's (NASDAQ: EBAY) PayPal has announced several initiatives aiming at offline merchant acceptance. According to Bank of America, these initiatives include, "1) 15 new national merchants; 2) partnerships with innovative mid-market...
Read More >> -
UPDATE: Jefferies Reduces PT to $6 on Leap Wireless International; Increased Pre-Paid Competition
Friday, May 25, 2012 - 9:20amJefferies reiterates its Hold rating on Leap Wireless International (NASDAQ: LEAP) and reduces its price target from $10 to $6. Jefferies comments, "As the post-paid market slows, we believe the Big-Four carriers are increasingly focusing on the pre-paid market to drive growth. Additionally, ARPU...
Read More >> -
UPDATE: Jefferies Reduces PT to $133 on Flowserve Corporation on Euro Weakness
Friday, May 25, 2012 - 9:17amJefferies reiterates its Buy rating on Flowserve Corporation (NYSE: FLS) but reduces its price target from $135 to $133. Jefferies notes, "We hosted investor meetings with the CFO. End-market activity is improving. Combined with new operating strategies, we expect continued sales momentum and...
Read More >> -
UPDATE: Jefferies Increases PT to $34 on Patterson Companies on Momentum Gains
Friday, May 25, 2012 - 9:16amJefferies raises its price target on Patterson companies (NASDAQ: PDCO) from $31 to $34 and reiterates a Hold rating on shares. Jefferies says, "PDCO's fiscal-4Q12 (Apr) EPS of $0.58 was $0.02 above consensus as stronger revenue growth & a lower tax rate more than offset a weaker than...
Read More >>
